Open AccessSupraventricular tachyarrhythmias: Drug therapy versus catheter ablation
Author(s) -
Scheinman Melvin
Publication year - 1994
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960171406
Subject(s) - medicine , atrial flutter , supraventricular arrhythmia , atrial fibrillation , catheter ablation , supraventricular tachycardia , cardiology , atrial tachycardia , ablation , pharmacotherapy , atrioventricular reentrant tachycardia , tachycardia , atrioventricular node , catheter , surgery , accessory pathway
Until recently, the only options available for treatment of supraventricular arrhythmias involved the use of drug therapy or cardiac surgery. However, over the past several years with the introduction of radiofrequency energy sources as well as steerable catheters, the clinician has a variety of additional nonpharmacologic options. This article reviews the use of pharmacologic therapy versus catheter ablation for the treatment of reentrant supraventricular arrhythmias, involving the atrioventricular junction and/or accessory atrioventricular connection, as well as arrhythmias emanating from the atria such as atrial fibrillation, atrial flutter, and atrial tachycardia.